These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15851032)

  • 1. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.
    Tu D; Blaha G; Moore PB; Steitz TA
    Cell; 2005 Apr; 121(2):257-70. PubMed ID: 15851032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action.
    Dunkle JA; Xiong L; Mankin AS; Cate JH
    Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17152-7. PubMed ID: 20876128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structures of four macrolide antibiotics bound to the large ribosomal subunit.
    Hansen JL; Ippolito JA; Ban N; Nissen P; Moore PB; Steitz TA
    Mol Cell; 2002 Jul; 10(1):117-28. PubMed ID: 12150912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the structures of several antibiotics bound to the bacterial ribosome.
    Bulkley D; Innis CA; Blaha G; Steitz TA
    Proc Natl Acad Sci U S A; 2010 Oct; 107(40):17158-63. PubMed ID: 20876130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding site of the bridged macrolides in the Escherichia coli ribosome.
    Xiong L; Korkhin Y; Mankin AS
    Antimicrob Agents Chemother; 2005 Jan; 49(1):281-8. PubMed ID: 15616307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations suggest why the A2058G mutation in 23S RNA results in bacterial resistance against clindamycin.
    Kulczycka-Mierzejewska K; Sadlej J; Trylska J
    J Mol Model; 2018 Jul; 24(8):191. PubMed ID: 29971530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the antibiotic activity of ketolides and azalides.
    Schlünzen F; Harms JM; Franceschi F; Hansen HA; Bartels H; Zarivach R; Yonath A
    Structure; 2003 Mar; 11(3):329-38. PubMed ID: 12623020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward the rational design of macrolide antibiotics to combat resistance.
    Pavlova A; Parks JM; Oyelere AK; Gumbart JC
    Chem Biol Drug Des; 2017 Nov; 90(5):641-652. PubMed ID: 28419786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct localization by cryo-electron microscopy of secondary structural elements in Escherichia coli 23 S rRNA which differ from the corresponding regions in Haloarcula marismortui.
    Matadeen R; Sergiev P; Leonov A; Pape T; van der Sluis E; Mueller F; Osswald M; von Knoblauch K; Brimacombe R; Bogdanov A; van Heel M; Dontsova O
    J Mol Biol; 2001 Apr; 307(5):1341-9. PubMed ID: 11292346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA.
    Garza-Ramos G; Xiong L; Zhong P; Mankin A
    J Bacteriol; 2001 Dec; 183(23):6898-907. PubMed ID: 11698379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insight into the antibiotic action of telithromycin against resistant mutants.
    Berisio R; Harms J; Schluenzen F; Zarivach R; Hansen HA; Fucini P; Yonath A
    J Bacteriol; 2003 Jul; 185(14):4276-9. PubMed ID: 12837804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific antibiotic-ribosome interactions: implications for drug development.
    Wilson DN; Harms JM; Nierhaus KH; Schlünzen F; Fucini P
    Biol Chem; 2005 Dec; 386(12):1239-52. PubMed ID: 16336118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA.
    Hansen LH; Mauvais P; Douthwaite S
    Mol Microbiol; 1999 Jan; 31(2):623-31. PubMed ID: 10027978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications.
    Halling SM; Jensen AE
    BMC Microbiol; 2006 Oct; 6():84. PubMed ID: 17014718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the entire course of telithromycin binding to Escherichia coli ribosomes.
    Kostopoulou ON; Petropoulos AD; Dinos GP; Choli-Papadopoulou T; Kalpaxis DL
    Nucleic Acids Res; 2012 Jun; 40(11):5078-87. PubMed ID: 22362747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
    Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
    Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
    Pereyre S; Renaudin H; Charron A; Bébéar C; Bébéar CM
    J Antimicrob Chemother; 2006 Apr; 57(4):753-6. PubMed ID: 16464889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells.
    Chittum HS; Champney WS
    Curr Microbiol; 1995 May; 30(5):273-9. PubMed ID: 7766155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin.
    Davydova N; Streltsov V; Wilce M; Liljas A; Garber M
    J Mol Biol; 2002 Sep; 322(3):635-44. PubMed ID: 12225755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis.
    Petropoulos AD; Kouvela EC; Dinos GP; Kalpaxis DL
    J Biol Chem; 2008 Feb; 283(8):4756-65. PubMed ID: 18079110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.